Indian Journal of Sleep Medicine

Register      Login

VOLUME 1 , ISSUE 4 ( October-December, 2006 ) > List of Articles

REVIEW ARTICLE

Optimizing CPAP

Citation Information : Optimizing CPAP. Indian Sleep Med 2006; 1 (4):189-195.

DOI: 10.5005/ijsm-1-4-189

License: CC BY-SA 4.0

Published Online: 01-10-2006

Copyright Statement:  Copyright © 2006; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230- 1235.
  2. Toussignat P, Cosio M, Levy RD, Groome PA. Quality of life years added by treatment of obstructive sleep apnea. Sleep 1994; 17: 52-60.
  3. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9–14.
  4. American Thoracic Society. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndrome. Am J Respir Crit Care Med 1994; 150: 1738–1745.
  5. Teschler H, Berthon-Jones M, Thompson A, Henkel A, Henry J, Kanietzko N. Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 154: 734–740.
  6. Lloberes P, Ballester E, Montserrat J, et. al. Comparison of manual and automatic CPAP titration in patients with sleep/ hypopnea syndrome. Am J Respir Crit Care Med 1996; 154: 1755–1758.
  7. Gleadhill IC, Schwartz AR, Schubert N, Wise RA, Permutt S, Smith PL. Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis 1991; 143: 1300–1303.
  8. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571–1579.
  9. Smith PL, Wise RA, Gold AR, Schwartz AR, Permutt S. Upper airway pressure–flow relationships in obstructive sleep apnea. J Appl Physiol 1988; 64: 789–795.
  10. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997; 52: 114–119.
  11. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–67.
  12. Frith RW, Cant BR. Severe obstructive sleep apnea treated with long term nasal continuous airway pressure. Thorax 1985: 40; 45-50.
  13. McEvoy RD, Thornton AT. Treatment of obstructive sleep apnea syndrome with nasal continuous positive airway pressure. Sleep 1984; 7: 313-25.
  14. Gislason T, Almqvist M, Eriksson G, Taube A, Boman G. Prevalence of sleep apnea syndrome among Swedish men. An epidemiological study. J Clin Epidemiol 1988; 41: 571- 6.
  15. Krieger J. Grucker D, Sforza E, Chambron J, Kurtz D. Left ventricular ejection fraction in obstructive sleep apnea. Effects of long-term treatment with nasal continuous positive airway pressure. Chest 1991; 100: 917-21.
  16. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116:1545–1549.
  17. Loredo JS, Ancoli-Israel S, Kim EJ, Lim WJ, Dimsdale JE. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep 2006; 29: 564-571.
  18. Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006 Jul 19; 3: CD001106.
  19. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: 1470-1476.
  20. Hoffstein V, Viner S, Mateika S, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992; 145: 841–845.
  21. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, Redline S. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173: 910-6.
  22. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479–482.
  23. Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993; 16: 545–549.
  24. Peled N, Abinader EG, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999; 34: 1744-1749.
  25. Pepin JL, Krieger J, Rodenstein D, Cornette A, Sforza E, Delguste P, Deschaux C, Grillier V, Levy P. Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med 1999; 160: 1124– 1129.
  26. Rosenthal L, Gerhardstein R, Lumley A, Guido P, Day R, Syron ML, Roth T. CPAP therapy in patients with mild OSA: implementation and treatment outcome. Sleep Med 2000; 1:215–220.
  27. Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 1995; 107: 375-381.
  28. Bamford CR, Quan SF. Bacterial meningitis. A possible complication of nasal continuous positive airway pressure therapy in a patient with obstructive sleep apnea syndrome and a mucocele. Sleep 1993; 16: 31-2.
  29. Stauffer JL Fayter NA, MacLurg BJ. Conjunctivitis from nasal CPAP apparatus. Chest 1984; 86: 802.
  30. Strumpf DA, Harrop P, Dobbin J, Millman RP. Massive epistaxis from nasal CPAP therapy. Chest 1989; 95: 1141.
  31. Meurice JC, Mergy J, Rostykus C, Dore P, Paquerreau J, Patte F. Atrial arrhythmia as a complication of nasal CPAP. Chest 1992; 102: 640-2.
  32. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-14.
  33. Guilleminault C, Abad VC. Obstructive sleep apnoea. Curr Treat Options Neurol 2004; 6: 309-317.
  34. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147: 887-95.
  35. Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest 1991; 100: 1019- 23.
  36. Mortimore IL, Whittle AT, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax 1998; 53: 290-292.
  37. lssa FG, Sullivan CE. The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 1986; 63: l0-17.
  38. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999; 116: 403-408.
  39. Pressman MR, Peterson DD, Meyer TJ, Harkins JP, Gurijala L. Ramp abuse. A novel form of patient noncompliance to administration of nasal continuous positive airway pressure for treatment of obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 1632–1634.
  40. Teschler H, Berthon-Jones M. Intelligent CPAP systems: clinical experience. Thorax 1998; 53: S49-S54.
  41. Meurice JC, Marc I, Sériès F. Efficiency of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996; 153: 794-798.
  42. Boudewyns A, Grillier-Lanoir V, Willemen MJ, De Cock WA, Van de Heyning PH, De Backer WA. Two months follow up of auto-CPAP treatment in patients with obstructive sleep apnoea. Thorax 1999; 54: 147-149.
  43. Series F. Is treatment of obstructive sleep apnea syndrome with auto-CPAP useful? Sleep 2000; 23: S161-S165.
  44. Konermann, M, Sanner, BM, Vyleta, M, et. al. Use of conventional and self-adjusting nasal continuous positive airway pressure for treatment of severe obstructive sleep apnea syndrome: a comparative study. Chest 1998; 113, 714-718.
  45. Massie CA, McArdle N, Hart RW, Schmidt-Nowara WW, Lankford A, Hudgel DW, Gordon N, Douglas NJ. Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med 2003; 167: 20-3.
  46. Fleury B, Rakotonanahary D, Hausser-Hauw C, Lebeau B, Guilleminault C. A laboratory validation study of the diagnostic mode of the Autoset system for sleep-related respiratory disorders. Sleep 1996; 19: 502–505.
  47. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice Parameters for the Use of Auto- Titrating Continuous Positive Airway Pressure Devices for Titrating Pressures and Treating Adult Patients with Obstructive Sleep Apnea Syndrome. An American Academy of Sleep Medicine Report. Sleep 2002; 25: 143–147.
  48. Gay PC, Herold DL, Olson EJ. A randomized, double-blind clinical trial comparing continuous positive airway pressure with a novel bilevel pressure system for treatment of obstructive sleep apnea syndrome. Sleep 2003; 26: 864- 9.
  49. Schafer H, Ewig S, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med 1998; 92: 208–215.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.